Stock listing
TSX:APS Aptose Biosciences Inc Stock
Follow Aptose Biosciences Inc into a list and get an email when it puts out news.
Delisted TSX:APS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- TSX:APS
- Asset type
- Stock
- Exchange
- TSX
- Currency
- CAD
What changed lately
Latest news release · Jun 30, 2026
Aptose Biosciences Announces Completion of Acquisition by Hanmi Pharmaceutical
Latest news
Aptose Biosciences Inc on 6ix
- News releases
- 11 in the last 12 months · 49 in all · newest Jun 30, 2026 · oldest 2010
- Calls
- 14 calls with a replay · 14 with a transcript · latest May 14, 2024
- Decks
- 7 decks · latest Mar 12, 2025
Where Aptose Biosciences Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:APS · This page · Delisted | TSX | Canada | CAD |
| NASDAQ:APTO · Delisted | NASDAQ | United States | USD |
Events
| Call | When | Status |
|---|---|---|
| Aptose Biosciences (APTO) Q1 2024 Earnings Call | Tue, May 14, 2024 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q4 2023 Earnings Call | Tue, Mar 26, 2024 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q3 2023 Earnings Call | Thu, Nov 09, 2023 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q2 2023 Earnings Call | Thu, Aug 10, 2023 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q1 2023 Earnings Call | Mon, May 08, 2023 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q4 2022 Earnings Call | Thu, Mar 23, 2023 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q3 2022 Earnings Call | Tue, Nov 01, 2022 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q2 2022 Earnings Call | Tue, Aug 02, 2022 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q1 2022 Earnings Call | Mon, May 09, 2022 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q4 2021 Earnings Call | Tue, Mar 22, 2022 · 5:00 PM ET | Replay |
All 14 calls
| Call | When | Status |
|---|---|---|
| Aptose Biosciences (APTO) Q3 2021 Earnings Call | Thu, Nov 11, 2021 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q2 2021 Earnings Call | Tue, Aug 03, 2021 · 5:00 PM ET | Replay |
| Aptose Biosciences (APTO) Q1 2021 Earnings Call | Tue, May 04, 2021 · 4:30 PM ET | Replay |
| Aptose Biosciences (APTO) Q3 2020 Earnings Call | Tue, Nov 10, 2020 · 5:00 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2025) | Investor deck | 23 slides | Mar 12, 2025 |
| Investor Presentation (January 2025) | Investor deck | 20 slides | Jan 13, 2025 |
| Investor Presentation (July 2024) | Investor deck | 20 slides | Jul 26, 2024 |
| Investor Presentation (January 2023) | Investor deck | 36 slides | Jan 6, 2023 |
| Investor Presentation (July 2022) | Investor deck | 25 slides | Jul 20, 2022 |
| Investor Presentation (June 2022) | Investor deck | 44 slides | Jun 27, 2022 |
| Investor Presentation (July 2018) | Investor deck | 30 slides | Jul 9, 2018 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Caroline M Loewy Other companies: eFFECTOR Therapeutics Inc (Director · Sep 9, 2023 – Jun 13, 2024 · Past); CERo Therapeutics Holdings, Inc. (Director · Oct 5, 2021 – Feb 14, 2024 · Past); Zogenix Inc (Director · Sep 21, 2020 – Mar 7, 2022 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – May 19, 2023 · Past) | Director · Dec 21, 2018 – Jan 18, 2022 · Past |
| Bernd R. Seizinger Other companies: Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); Aprea Therapeutics, Inc. (Director · Since at least Oct 2, 2019) | Director · Sep 13, 2022 – Feb 5, 2024 · Past |
| Denis R Burger Other companies: CytoDyn Inc. (Director · Feb 7, 2014 – Jul 12, 2018 · Past); Sarepta Therapeutics, Inc. (Chief Executive Officer, Director · Feb 16, 2006 – Apr 3, 2007 · Past) | Director · Dec 21, 2018 – Feb 5, 2024 · Past |
| Jotin Marango Other companies: ImageneBio, Inc. (Chief Financial Officer · Since at least Apr 25, 2022) | Senior VP, CFO, and CBO · Jun 3, 2019 – Jan 18, 2022 · Past |
| Brian Underdown | Until Jan 20, 2015 · Past |
| Erich Platzer | Director · Dec 15, 2014 – Feb 5, 2024 · Past |
| Philippe Ledru | Sr VP & Ch Commerical Officer · Feb 5, 2024 – Feb 5, 2024 · Past |
| Rafael Bejar | Sr VP & Chief Medical Officer · Jan 4, 2021 – Feb 5, 2024 · Past |
| Warren Whitehead | Director · Dec 21, 2018 – Feb 5, 2024 · Past |
| William G Rice | Chair, President & CEO, Director · Since at least Jan 4, 2021 |
Log in to ask 6ix AI your own questions about Aptose Biosciences Inc.